Marijuana Inc. (MAJI) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Marijuana Inc. (MAJI) trades at $0.008. Marijuana Inc. distributes cannabis products within the United States. Formerly GRN Holding Corporation, the company rebranded in October 2024 and is based in Estero, Florida. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026Analyst Coverage for MAJI: MAJI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MAJI against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
MAJI: the 3 scored disciplines are evenly split. Dominant signal: Seth Klarman bullish.
How is this calculated? →Marijuana Inc. (MAJI) Healthcare & Pipeline Overview
Marijuana Inc. distributes cannabis products in the United States, operating within the specialty and generic drug manufacturing sector. Founded in 2010, the company focuses on distribution, facing competition and regulatory hurdles in the evolving cannabis market. It has a market capitalization of $0.00B.
What Is the Investment Thesis for MAJI?
Marijuana Inc. presents a speculative investment opportunity within the cannabis distribution sector. The company's small market capitalization ($0.00B) and negative P/E ratio (-12.70) indicate it is not currently profitable. The company's high beta of -4.81 suggests high volatility relative to the market. Growth depends on navigating the evolving regulatory landscape of the cannabis industry and expanding its distribution network. Investors should carefully consider the risks associated with OTC-traded companies and the competitive pressures within the cannabis market. The company's future hinges on its ability to achieve profitability and scale its operations effectively.
Based on FMP financials and quantitative analysis
MAJI Key Highlights
Market capitalization of $0.00B indicates a micro-cap company with limited financial resources.
- Negative P/E ratio of -12.70 suggests the company is currently not profitable.
- Beta of -4.81 indicates high volatility and a negative correlation with the overall market.
- The company operates in the evolving cannabis industry, which is subject to changing regulations and market dynamics.
- The company changed its name from GRN Holding Corporation to Marijuana Inc. in October 2024, reflecting a strategic shift towards the cannabis market.
Who Are MAJI's Competitors?
MAJI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| INNPF INNOCAN PHARMA Corp | $1.60 | -8.05% | $7.20M | 61 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.3M | 63 |
| GBLP Global Pharmatech, Inc. | $0.08 | +0.00% | $33.3M | 62 |
| ETST Earth Science Tech, Inc. | $0.12 | +14.45% | $35.3M | 61 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.1M | 64 |
| MNNGF Baijin Life Science Holdings Limited | $0.08 | +0.00% | $74.6M | 63 |
| SHIEF Shield Therapeutics plc | $0.07 | +0.00% | $75.3M | 62 |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109M | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MAJI's Key Strengths?
Established distribution network within the United States.
- Focus on the growing cannabis market.
- Experience in navigating the regulatory landscape.
- Potential for brand development.
What Are MAJI's Weaknesses?
Small size and limited resources.
- Negative profitability and low market capitalization.
- High volatility and dependence on regulatory changes.
- Limited product diversification.
What Could Drive MAJI Stock Higher?
Increasing legalization of cannabis in additional states, expanding the company's potential market reach.
- Growing acceptance of cannabis for medical and recreational use, driving demand for cannabis products.
- Potential for new partnerships with retailers and dispensaries to expand distribution network.
- Development and launch of branded cannabis products to differentiate from competitors.
- Exploration of strategic acquisitions to consolidate market position.
What Are the Key Risks for MAJI?
Financial-distress signal — its Altman Z-Score of 1.24 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Intense competition from larger cannabis companies with greater resources.
- Changing regulations and potential for increased restrictions on cannabis distribution.
- Fluctuations in cannabis prices and demand, impacting profitability.
- Difficulty accessing capital and financing due to the stigma associated with the cannabis industry.
- Legal challenges and compliance costs associated with operating in a highly regulated industry.
What Are the Growth Opportunities for MAJI?
- Growth opportunity 1: Expanding distribution network: Marijuana Inc. can grow by expanding its distribution network to new states and regions where cannabis is legal. This involves establishing partnerships with retailers, dispensaries, and other distribution channels. The timeline for expansion depends on regulatory approvals and market entry strategies. A competitive advantage can be achieved by building strong relationships with key retailers and offering efficient and reliable distribution services.
- Growth opportunity 2: Developing branded products: Marijuana Inc. can develop its own branded cannabis products to differentiate itself from competitors and capture higher profit margins. This involves investing in product development, branding, and marketing. The market for branded cannabis products is growing rapidly as consumers seek trusted and recognizable brands. The timeline for launching branded products depends on product development cycles and regulatory approvals. A competitive advantage can be achieved by creating high-quality, innovative products that meet consumer needs.
- Growth opportunity 3: Entering new therapeutic areas: Marijuana Inc. can expand into new therapeutic areas by developing cannabis-based products for specific medical conditions. This involves conducting research and clinical trials to demonstrate the efficacy and safety of its products. The market for medical cannabis is growing as more patients and healthcare providers recognize the potential benefits of cannabis for treating various conditions. The timeline for entering new therapeutic areas depends on research and development timelines and regulatory approvals. A competitive advantage can be achieved by developing innovative and effective cannabis-based therapies.
- Growth opportunity 4: Strategic acquisitions: Marijuana Inc. can grow through strategic acquisitions of other companies in the cannabis industry. This involves identifying and acquiring companies with complementary assets, technologies, or market access. The market for cannabis acquisitions is active, with numerous companies seeking to consolidate their positions. The timeline for acquisitions depends on deal negotiations and regulatory approvals. A competitive advantage can be achieved by acquiring companies with strong brands, distribution networks, or intellectual property.
- Growth opportunity 5: International expansion: Marijuana Inc. can expand its operations internationally by entering new markets where cannabis is legal or becoming legal. This involves navigating international regulations, establishing partnerships with local companies, and adapting its products and services to local market needs. The global cannabis market is growing rapidly, with numerous countries legalizing cannabis for medical or recreational use. The timeline for international expansion depends on regulatory developments and market entry strategies. A competitive advantage can be achieved by establishing a strong presence in key international markets.
What Are MAJI's Competitive Advantages?
- Established distribution network within specific regions.
- Potential brand recognition if branded products are developed.
- Expertise in navigating the complex regulatory landscape of the cannabis industry.
- Relationships with key retailers and suppliers in the cannabis market.
What Does MAJI Do?
Marijuana Inc., headquartered in Estero, Florida, operates as a distributor of cannabis products within the United States. The company was established in 2010 and initially functioned under the name GRN Holding Corporation. In October 2024, the company underwent a rebranding, officially changing its name to Marijuana Inc. This change reflects the company's strategic focus on the cannabis market. Marijuana Inc. navigates a complex regulatory landscape, typical of the cannabis industry, while focusing on distribution channels. The company's operations are concentrated within the United States, where it aims to capitalize on the increasing acceptance and legalization of cannabis products across various states. As a distributor, Marijuana Inc. plays a role in connecting cannabis producers with retailers and consumers, managing logistics, and ensuring compliance with local regulations. The company's small size, with only two employees, suggests a lean operational structure, possibly relying on outsourcing or partnerships for various functions. The company's success depends on its ability to adapt to changing market dynamics, regulatory changes, and competitive pressures within the cannabis industry.
What Products and Services Does MAJI Offer?
- Distributes cannabis products within the United States.
- Connects cannabis producers with retailers and consumers.
- Manages logistics and supply chain for cannabis products.
- Ensures compliance with local regulations regarding cannabis distribution.
- Focuses on expanding its distribution network across various states.
- Potentially develops its own branded cannabis products.
- May explore strategic acquisitions within the cannabis industry.
How Does MAJI Make Money?
- Generates revenue by distributing cannabis products to retailers and dispensaries.
- Potentially earns revenue through the sale of branded cannabis products.
- May generate revenue through licensing or franchising agreements.
- Profitability depends on efficient supply chain management and regulatory compliance.
What Industry Does MAJI Operate In?
Marijuana Inc. operates within the rapidly evolving cannabis industry, which is characterized by increasing legalization and acceptance in various regions. The market is highly competitive, with numerous players vying for market share in cultivation, processing, distribution, and retail. The industry is subject to stringent regulations, which vary significantly by jurisdiction. Companies must navigate complex licensing requirements, quality control standards, and restrictions on marketing and sales. The overall market is experiencing substantial growth, driven by increasing consumer demand and expanding medical applications. However, companies like Marijuana Inc. face challenges related to competition, regulatory compliance, and access to capital.
Who Are MAJI's Key Customers?
- Retail dispensaries selling cannabis products to consumers.
- Medical cannabis patients seeking cannabis-based therapies.
- Recreational cannabis users in states where it is legal.
- Potentially, other businesses in the cannabis industry through B2B partnerships.
Financial Health
Marijuana Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 1.24 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Return on equity for Marijuana Inc. stands at 61.1%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -48.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.02 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -95.6%, the inverse of the P/E and a quick read on earnings relative to price.
Company Profile
Marijuana Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Estero, US. The company is led by CEO Donald J. Steinberg. MAJI has traded publicly since 2012.
Insider Activity
The most recent 12 insider filings for Marijuana Inc. break down as 2 sales and 10 purchases. On net that is roughly 13.5M shares disposed (about $15K), a signal worth weighing alongside the fundamentals.
MAJI Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future, indicating that leadership believes in upcoming growth opportunities.
- Community sentiment has shifted positively, with increased discussions about potential partnerships and market expansion in the cannabis sector.
- New product launches have generated excitement among consumers, potentially boosting brand visibility and market share.
- Regulatory developments are becoming more favorable, which could enhance the overall market environment for cannabis businesses.
Bear Case
- Concerns over market saturation in the cannabis industry are growing, leading some investors to question long-term profitability.
- Social sentiment has shown skepticism about the company's ability to compete against larger, established players in the market.
- Recent reports of operational challenges have surfaced, raising doubts about management's effectiveness and execution of strategy.
- Investor sentiment is cautious due to broader economic conditions impacting discretionary spending, which could affect sales.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
MAJI Latest News
No recent news available for MAJI.
MAJI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MAJI.
Price Targets
Wall Street price target analysis for MAJI.
MAJI MoonshotScore
What does this score mean?
The MoonshotScore rates MAJI 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Donald J. Steinberg
Managing
Donald J. Steinberg currently manages Marijuana Inc., overseeing a small team of two employees. Information regarding his prior experience and educational background is not available. His role involves directing the company's distribution efforts within the cannabis market. Given the company's size, his responsibilities likely encompass a wide range of operational and strategic functions.
Track Record: Due to limited information available, it is difficult to assess Donald J. Steinberg's track record at Marijuana Inc. Key milestones and strategic decisions under his leadership are not publicly documented. The company's recent name change in October 2024 to Marijuana Inc. suggests a strategic shift during his tenure. Further information is needed to evaluate his performance and contributions to the company's growth and development.
MAJI OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Marijuana Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies on the OTC Other tier often have limited trading volume and may not be required to provide audited financial statements. Investing in companies on this tier carries significant risks due to the lack of transparency and regulatory oversight compared to exchanges like the NYSE or NASDAQ. This tier is often populated by shell companies, bankrupt entities, or companies with questionable operations.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- High risk of fraud or misrepresentation.
- Potential for price manipulation due to low trading volume.
- Illiquidity and difficulty exiting a position.
- Lack of regulatory oversight and investor protection.
- Verify the company's legal status and registration.
- Obtain and review any available financial statements.
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's compliance with relevant regulations.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a qualified financial advisor.
- Company has been in operation since 2010.
- Company is registered in Florida.
- Company's name change reflects a strategic focus on the cannabis market.
Marijuana Inc. Healthcare Stock: Key Questions Answered
What does Marijuana Inc. do?
Marijuana Inc. operates as a distributor of cannabis products within the United States. The company connects cannabis producers with retailers and consumers, managing the logistics and supply chain involved in distributing these products. Marijuana Inc. focuses on ensuring compliance with local regulations regarding cannabis distribution.
What do analysts say about MAJI stock?
As of 2026-03-16, there is no available analyst coverage or consensus on Marijuana Inc. due to its small market capitalization, OTC listing, and limited financial disclosure. Key valuation metrics such as price targets and earnings estimates are not available. Investors should conduct their own thorough research and due diligence before considering an investment in Marijuana Inc., taking into account the risks associated with OTC-traded companies and the cannabis industry.
What are the main risks for MAJI?
Marijuana Inc. faces several key risks, including intense competition from larger cannabis companies, changing regulations and potential for increased restrictions on cannabis distribution, fluctuations in cannabis prices and demand, difficulty accessing capital and financing, and legal challenges and compliance costs. The company's OTC listing and limited financial disclosure also pose additional risks for investors. Investors should carefully consider these risks before investing in Marijuana Inc.
What are the key factors to evaluate for MAJI?
Evaluate MAJI on fundamentals, analyst consensus, and risk factors. P/E: 0.0x vs the S&P 500's ~20-25x. Marijuana Inc. Not financial advice.
How frequently does MAJI data refresh on this page?
MAJI's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven MAJI's recent stock price performance?
Marijuana Inc. (MAJI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established distribution network within the United States. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MAJI overvalued or undervalued right now?
Marijuana Inc. (MAJI) trades at 0.0x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research MAJI before investing?
Before investing in Marijuana Inc. (MAJI), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on Marijuana Inc. due to its OTC listing and small size.
- Financial data is based on available information and may not be comprehensive.
- AI analysis is pending and may provide further insights.